Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.
Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.
National Institutes of Health - National Cancer Institute
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH, External PI, Principal Investigator
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Risk-Benefit Trade-Offs for Whole Genome Sequencing
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator